Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04291014 · ClinicalTrials.gov registry record · NA
Light Therapy for PD - Dose Selection
A NA study of Parkinson Disease and Fatigue, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 203
- Enrollment target
- 20
- Study locations
NCT04291014 is a NA study of Parkinson Disease and Fatigue that has completed, run by Massachusetts General Hospital. The registered enrollment target is 203 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT04291014, a NA study of Parkinson Disease and Fatigue, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 203 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study aims to determine the most effective dose of light therapy to improve sleep in people with Parkinson's Disease. Four groups of participants will receive bright-white or dim-red light therapy at different times throughout the day.
Conditions Studied
Interventions
- DEVICE SunRay Light Boxes
Study Locations (20)
New York
- Weill Cornell - New York
- Mount Sinai - Icahn School of Medicine - New York
- University of Rochester - Rochester
- SUNY Stonybrook - Stony Brook
- SUNY Upstate - Syracuse
California
- UC Irvine - Irvine
- UC Davis - Sacramento
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Ohio
- University of Cincinnati - Cincinnati
- Ohio State University - Columbus
Alabama
- University of Alabama - Birmingham
Arizona
- Barrow Neurological Institute - Phoenix
Connecticut
- Yale University - Fairfield
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2020-09-11 |
| Est. Completion | 2023-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04291014
The ClinicalTrials.gov registry entry for NCT04291014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (96% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which SunRay Light Boxes is the first listed.
NCT04291014 reports 20 study locations spanning 13 distinct geographic areas - top geographies include New York, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04291014 about?
NCT04291014 is a clinical study titled "Light Therapy for PD - Dose Selection". This study aims to determine the most effective dose of light therapy to improve sleep in people with Parkinson's Disease. Four groups of participants will receive bright-white or dim-red light therapy at different times throughout the day.
What is the current status of trial NCT04291014?
This trial is currently completed. It is a NA study. The enrollment target is 203 participants. The study started on 2020-09-11. Estimated completion is 2023-01-10.
What conditions does trial NCT04291014 study?
This clinical trial studies the following conditions: Parkinson Disease, Fatigue, Sleep Disorder.
What interventions are being tested in trial NCT04291014?
The interventions under investigation include: SunRay Light Boxes (DEVICE).
Who is sponsoring clinical trial NCT04291014?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04291014 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.